FeetMe is a digital health company founded in 2013 in France. The company focuses on improving patient outcomes in functional care, tracking disease advancement, and enhancing medication usage through connected technologies and services. By utilizing pressure sensors, motion sensors, and learning algorithms, FeetMe's groundbreaking technology allows real-time analysis of gait and posture in day-to-day situations, particularly benefiting individuals diagnosed with gait disorders.
The company recently received a Series B investment on June 6, 2024, with participation from notable investors SOSV and HAX. FeetMe's dedication to leveraging analytics, hardware, and technology to elevate health and wellness places it at the forefront of innovation in the healthcare and sports industries. For further details, visit www.feetme.fr.